Clinical Trial Update: Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

View source ↗

Summary

This clinical trial will investigate the real-world usage of HyQvia in adults with multiple myeloma and secondary immunodeficiency. The study status is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency
• Multiple Myeloma

Drugs mentioned

• HYQVIA (immunoglobulin G (IgG) with recombinant human hyaluronidase)

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma, Secondary Immunodeficiency (SID) | Status: RECRUITING